Almirall, Forest to seek approval for inhaler drug in US, Europe
May 02, 2013 at 03:47 AM EDT
MADRID, May 2 (Reuters) - Spain's Almirall and Forest Laboratories said on Thursday that results of a second phase III clinical trial for a new inhaler were positive and they will seek regulatory approval to sell the drug by the end of the year.
